...
首页> 外文期刊>Thrombosis and Haemostasis: Journal of the International Society on Thrombosis and Haemostasis >The effect of hyperthyroidism on procoagulant, anticoagulant and fibrinolytic factors: A systematic review and meta-analysis
【24h】

The effect of hyperthyroidism on procoagulant, anticoagulant and fibrinolytic factors: A systematic review and meta-analysis

机译:甲状腺功能亢进症对促凝,抗凝和纤溶因子的影响:系统评价和荟萃分析

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Several coagulation and fibrinolytic parameters appear to be affected by thyroid hormone excess; however, the net effect on the haemostatic system remains unclear. We aimed to update our previous review and systematically summarise and meta-analyse the data by assessing the effects of thyrotoxicosis on the coagulation and fibrinolytic system in vivo. Data sources included MEDLINE (2006-2012), EMBASE (2006-2012), and reference lists. The sources were combined with our previous search containing studies from 1980-2006. Eligible studies were all observational or experimental studies. Two investigators independently extracted data and rated study quality. Weighted mean proportion and 95% confidence intervals were calculated and pooled using a fixed and a random-effects model. A total of 29 articles consisting of 51 studies were included, as in several articles more than one study was described. We included four intervention (before and after treatment in hyperthyroid patients), five cross-sectional (hyperthyroid subjects and euthyroid controls), and four experimental (before and after use of thyroid hormone in euthyroid subjects) medium/high quality studies for meta-analysis. We found that thyrotoxicosis shifts the haemostatic balance towards a hypercoagulable and hypofibrino-lytic state with a rise in factors VIII and IX, fibrinogen, von Willebrand factor, and plasminogen activator inhibitor-1. This was observed in endogenous and exogenous thyrotoxicosis, and in subclinical as well as overt hyperthyroidism. We conclude that both subclinical and overt hy-perthyroidism induce a prothrombotic state, which is therefore likely to be a risk factor for venous thrombosis.
机译:甲状腺激素过多会影响一些凝血和纤溶参数。但是,对止血系统的净作用尚不清楚。我们旨在更新以前的综述,并通过评估甲状腺毒症对体内凝血和纤溶系统的影响来系统总结和荟萃分析数据。数据来源包括MEDLINE(2006-2012),EMBASE(2006-2012)和参考列表。资料与我们以前的搜索结合在一起,其中包含1980-2006年的研究。符合条件的研究均为观察性或实验性研究。两名研究者独立提取数据并评估研究质量。使用固定和随机效应模型计算并合并加权平均比例和95%置信区间。总共包括29篇文章,包括51项研究,因为在几篇文章中,描述了一项以上的研究。我们包括四项干预措施(甲状腺功能亢进患者治疗前后),五项横断面(甲状腺功能亢进患者和正常甲状腺对照)和四项实验性(高质量甲状腺激素患者使用甲状腺激素前后)荟萃分析。我们发现,甲状腺毒症会使止血平衡向高凝和低纤维蛋白溶解状态转移,并伴有因子VIII和IX,纤维蛋白原,von Willebrand因子和纤溶酶原激活物抑制剂-1的增加。在内源性和外源性甲状腺毒症,亚临床以及明显的甲状腺功能亢进症中都观察到了这一现象。我们得出的结论是,亚临床性甲状腺功能亢进症和明显的甲状腺功能亢进症均可诱发血栓前状态,因此很可能是静脉血栓形成的危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号